HLB Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 19, 2026	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Market Capitalization	222,430	75,194	58,507	80,206
Market Cap Growth	-41.66%	28.52%	-27.05%	-
Enterprise Value	212,775	77,595	-	-
Last Close Price	15840.00	5430.00	4225.00	6420.00
PE Ratio	470.60	159.09	-	-
PS Ratio	6.16	2.08	2.85	5.16
PB Ratio	12.42	4.20	3.44	4.77
P/TBV Ratio	12.74	4.31	3.50	4.83
P/OCF Ratio	164.36	55.56	-	-
EV/Sales Ratio	5.89	2.15	-	-
EV/EBITDA Ratio	69.07	25.19	-	-
EV/EBIT Ratio	147.67	53.85	-	-
Debt / Equity Ratio	0.74	0.74	0.45	0.89
Debt / EBITDA Ratio	4.28	4.28	-	-
Net Debt / Equity Ratio	-0.11	-0.11	-0.08	0.21
Net Debt / EBITDA Ratio	-0.64	-0.64	0.30	-1.27
Net Debt / FCF Ratio	44.86	44.86	0.49	-1.18
Asset Turnover	0.88	0.88	0.54	-
Inventory Turnover	3.27	3.27	3.13	-
Quick Ratio	1.01	1.01	0.94	1.01
Current Ratio	1.26	1.26	1.31	1.31
Return on Equity (ROE)	2.71%	2.71%	-41.77%	-
Return on Assets (ROA)	2.19%	2.19%	-9.55%	-
Return on Capital Employed (ROCE)	6.30%	6.30%	-28.80%	-17.40%
Earnings Yield	0.21%	0.63%	-12.07%	-6.79%
FCF Yield	-0.02%	-0.06%	-4.91%	-3.77%
Buyback Yield / Dilution	-2.30%	-2.30%	-13.08%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.